List of works - Björn Holzhauer

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials

scientific article published on 23 February 2010

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

scientific article published on 20 November 2015

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension

scientific article published on 06 January 2021

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk

scientific article published on 06 January 2021

Choice of estimand and analysis methods in diabetes trials with rescue medication

scientific article published on 4 September 2015

Effect of nateglinide on the incidence of diabetes and cardiovascular events

scientific article published on 14 March 2010

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

scientific article published on 17 January 2017

Effect of valsartan on the incidence of diabetes and cardiovascular events

scientific article

Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis

scientific article published on 20 November 2017

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.

scientific article

Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

scientific article published on 24 August 2017

Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack

scientific article published on 07 October 2014

Meta-analysis of aggregate data on medical events

scientific article

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

scientific article published on 29 October 2015

Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial

scientific article published on 25 January 2016

Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

scientific article

Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension

scientific article published on 9 December 2011

List of works by Björn Holzhauer

Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus and hypertension

Cardiovascular outcomes at recommended blood pressure targets in middle-aged and elderly patients with type 2 diabetes mellitus compared to all middle-aged and elderly hypertensive study patients with high cardiovascular risk

Choice of estimand and analysis methods in diabetes trials with rescue medication

Effect of nateglinide on the incidence of diabetes and cardiovascular events

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

Effect of valsartan on the incidence of diabetes and cardiovascular events

Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.

Fevipiprant, an oral prostaglandin DP2 receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

Heart rate as a predictor of stroke in high-risk, hypertensive patients with previous stroke or transient ischemic attack

Meta-analysis of aggregate data on medical events

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial

Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studies

Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension